FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ian Thompson

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Geographic Areas

United States

Anatomy

Prostate

Co-author Network

Publications

TOP 3
Chun-Liang Chen; Maria Gaczynska; Tien-Cheng Chang; Rohit R Jadhav; Addanki Pratap Kumar; Robin J Leach; Devalingam Mahalingam; Pawel Osmulski; Luzhe Sun; Ian M Thompson; Chiou-Miin Wang; Steven D Weitman; Tim Hui-Ming Huang
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.
Maha Hussain; Subramanian Kanaga Sundaram; Glenn Liu; Carol M Moinpour; Stephen Prescott; David I Quinn; Derek Raghavan; Paul F Schellhammer; Eric Jay Small; Catherine M Tangen; Donna L Berry; E David Crawford; Nancy Ann Dawson; Bryan J Donnelly; Benjamin Ely; Celestia S Higano; Ulka N Vaishampayan; Peter M Venner; Nicholas J Vogelzang; George Wilding; Ian M Thompson
Intermittent versus continuous androgen deprivation in prostate cancer.
Ruth Etzioni; Roman Gulati; David M Penson; Matt R Cooperberg; Noel S Weiss; Ian M Thompson
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ian Thompson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chun-Liang Chen; Maria Gaczynska; Tien-Cheng Chang; Rohit R Jadhav; Addanki Pratap Kumar; Robin J Leach; Devalingam Mahalingam; Pawel Osmulski; Luzhe Sun; Ian M Thompson; Chiou-Miin Wang; Steven D Weitman; Tim Hui-Ming Huang
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.
The Prostate 2013;73(8):813-26.
2013: Maha Hussain; Subramanian Kanaga Sundaram; Glenn Liu; Carol M Moinpour; Stephen Prescott; David I Quinn; Derek Raghavan; Paul F Schellhammer; Eric Jay Small; Catherine M Tangen; Donna L Berry; E David Crawford; Nancy Ann Dawson; Bryan J Donnelly; Benjamin Ely; Celestia S Higano; Ulka N Vaishampayan; Peter M Venner; Nicholas J Vogelzang; George Wilding; Ian M Thompson
Intermittent versus continuous androgen deprivation in prostate cancer.
The New England journal of medicine 2013;368(14):1314-25.
2013: Ruth Etzioni; Roman Gulati; David M Penson; Matt R Cooperberg; Noel S Weiss; Ian M Thompson
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening.
Medical care 2013;51(4):295-300.
2013: Ian M Thompson; Robin J Leach
Prostate cancer and prostatic intraepithelial neoplasia: true, true, and unrelated?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(5):515-6.
2013: Marian L Neuhouser; Howard L Parnes; Elizabeth A Platz; William D Figg; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing; Alan Kristal; M Scott Lucia; Catherine M Tangen; Yuzhen Tao; Ian M Thompson; Cathee Till; Michael Pollak
Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.
Cancer prevention research (Philadelphia, Pa.) 2013;6(2):91-9.
2012: William M Hilton; Robin J Leach; Susan S Padalecki; Donna P Ankerst; Ian M Thompson
Temporal changes in the clinical approach to diagnosing prostate cancer.
Journal of the National Cancer Institute. Monographs 2012;2012(45):162-8.
2012: Catherine M Tangen; Nicholas J Vogelzang; George Wilding; E David Crawford; Bryan J Donnelly; Mario A Eisenberger; Celestia S Higano; Maha Hussain; Isaac J Powell; Paul F Schelhammer; Eric J Small; Ian M Thompson
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346).
The Journal of urology 2012;188(4):1164-9.
2012: Laurence Klotz; Ian M Thompson
Re: Active surveillance versus surgery for low risk prostate cancer: a clinical decision analysis: D. Liu, H. P. Lehmann, K. D. Frick and H. B. Carter. J Urol 2012; 187: 1241-1246.
The Journal of urology 2012;188(4):1400; author reply 1400.
2012: Alan R Kristal; Scott M Lippman; Marian L Neuhouser; Sherfaraz K Patel; Elizabeth A Platz; Juergen K Reichardt; Frank Z Stanczyk; Catherine M Tangen; Ian M Thompson; Cathee Till; Adrie Van Bokhoven; Lisa W Chu; William D Figg; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing
Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(10):1823-32.
2012: Carol M Moinpour; Donald L Patrick; Sally A Shumaker; R. Duane Duane Cespedes; Amy K Darke; Gary W Donaldson; Patricia Anne Ganz; Christine R Johnson; Frank L Meyskens; John Ware; Ian M Thompson
Health-related quality-of-life findings for the prostate cancer prevention trial.
Journal of the National Cancer Institute 2012;104(18):1373-85.
2012: Yuanyuan Liang; Ian M Thompson; Fei Du; Barbara J Turner
Limited PSA testing in indigent men in South Texas: an appropriate care or missing a prevention opportunity?
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1489-96.
2012: Siobhan Sutcliffe; Ian M Thompson; Cathee Till; Jonathan M Zenilman; Angelo M DeMarzo; Charlotte A Gaydos; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Frank J Jenkins; William G Nelson; Elizabeth A Platz
Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Cancer causes & control : CCC 2012;23(9):1511-8.
2012: Ethan Basch; Philip Kantoff; D Andrew Loblaw; Thomas K Oliver; Howard Parnes; Bruce Roth; Ian M Thompson; Andrew Vickers; James Williams; Robert K Nam
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(24):3020-5.
2012: Tao Liu; Wei-Jun Qian; Karin D Rodland; Athena A Schepmoes; Tujin Shi; Richard D Smith; Lori J Sokoll; Sudhir Srivastava; Ian M Thompson; Daniel W Chan; Thomas L Fillmore; Mahmud Hossain; Grant Izmirlian; Jacob Kagan; Scott R Kronewitter; Robin J Leach; David G Camp
Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.
Journal of proteomics 2012;75(15):4747-57.
2012: J Kellogg Parsons; Jeannette M Schenk; Ian M Thompson; Cathee Till; Kathryn B Arnold; Alan R Kristal; Karen Messer
Finasteride reduces the risk of incident clinical benign prostatic hyperplasia.
European urology 2012;62(2):234-41.
2012: Ian M Thompson; Catherine M Tangen
Prostate cancer--uncertainty and a way forward.
The New England journal of medicine 2012;367(3):270-1.
2012: Jeannette M Schenk; Catherine M Tangen; Ian M Thompson; Gregory S Calip; Phyllis Goodman; J Kellogg Parsons; Alan R Kristal
Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
American journal of epidemiology 2012;176(2):156-63.
2012: Chunyu Li; Carol M Moinpour; David F Penson; Donatus U Ekwueme; Ingrid J Hall; Thomas E Keane; Judith Lee Smith; Ian M Thompson; Steven B Zeliadt; Scott D Ramsey
Willingness to pay for prostate cancer treatment among patients and their family members at 1 year after diagnosis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2012;15(5):716-23.
2012: Donna P Ankerst; Ian M Thompson
Words of wisdom. Re: Combining 33 genetic variants with prostate-specific antigen for the prediction of prostate cancer: longitudinal study.
European urology 2012;62(1):180.
2012: Robin J Leach; Ian M Thompson
The dilemma of prostate-specific antigen testing.
Archives of internal medicine 2012;172(11):835-6.
2012: Yair Lotan; Shahrokh F Shariat; Robert S Svatek; Catherine M Tangen; Ian M Thompson; Ramy F Youssef; Phyllis J Goodman; Eric A Klein
Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT.
The Journal of urology 2012;187(6):2005-10.
2012: Anand P Chokkalingam; L W Chu; Angelo M DeMarzo; R N Hoover; A Adjei; Richard B Biritwum; D Chia; S Jadallah; Y Li; GEORGES NETTO; S Niwa; Alan W Partin; C Roehrborn; Y Tettey; Ian M Thompson; E D Yeboah; K Yu; Ann W Hsing
Prevalence of BPH and lower urinary tract symptoms in West Africans.
Prostate cancer and prostatic diseases 2012;15(2):170-6.
2012: Stephen B Williams; Ian M Thompson; John T Wei; Donna P Ankerst; Meredith M Regan; Mark A Rubin; Simpa Salami; Martin G Sanda
Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.
Cancer 2012;118(10):2651-8.
2012: Ian M Thompson; Donna Pauler Ankerst
Editorial for special issue on epidemiology and prevention of prostate cancer.
World journal of urology 2012;30(2):129-30.
2012: Eric A Klein; Ian M Thompson
Chemoprevention of prostate cancer: an updated view.
World journal of urology 2012;30(2):189-94.
2012: Donna Pauler Ankerst; Amine Benchikh; Andreas Boeck; Angel M Cronin; Jenny Donovan; Stephen J Freedland; Freddie Hamdy; Wolfgang Horninger; Jonas Hugosson; Michael W Kattan; Eric A Klein; Helmut Klocker; Hans Lilja; Daniel M Moreira; David Neal; Dipen J Parekh; Monique J Roobol; Gilles Salama; Fritz H Schröder; J Stephen Jones; Ian M Thompson; Arnauld Villers; Andrew J Vickers
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
World journal of urology 2012;30(2):181-7.
2012: Ian M Thompson; Donna P Ankerst
The benefits of risk assessment tools for prostate cancer.
European urology 2012;61(4):662-3.
2012: Ryan K Berglund; Edith D Canby-Hagino; Peter R Carroll; E David Crawford; Ralph W deVere White; Gabriel P Haas; George P Hemstreet; Bruce A Lowe; Isaac J Powell; Catherine M Tangen; Ian M Thompson; Eric A Klein
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.
Urology 2012;79(3):633-7.
2012: Roble Bedolla; Rita Ghosh; Jingjing Gong; Thomas J Prihoda; Ian M Thompson; I-Tien Yeh; Addanki Kumar
Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.
PloS one 2012;7(9):e44917.
2012: Yuanyuan Liang; Christopher Louden; Ian M Thompson; Miguel A Jimenez-Rios; Norma S Ketchum; Hector R Camarena-Reynoso
The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.
Urologia internationalis 2012;89(1):9-16.
2012: Donna P Ankerst; Yuanyuan Liang; Martin G Sanda; Tim Koniarski; Alan W Partin; Lori J Sokoll; Robin J Leach; Jacob Kagan; Daniel W Chan; John T Wei; Ziding Feng; Ian M Thompson
Updating risk prediction tools: a case study in prostate cancer.
Biometrical journal. Biometrische Zeitschrift 2012;54(1):127-42.
2011: James R Marshall; Lori M Minasian; Howard L Parnes; Michael Ray; Wael A Sakr; Catherine M Tangen; David P Wood; David S Alberts; Donna L Berry; E David Crawford; Warren Davis; Benjamin Ely; J Michael Gaziano; David F Jarrard; Eric A Klein; W Robert Lee; Scott M Lippman; Ian M Thompson
Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Cancer prevention research (Philadelphia, Pa.) 2011;4(11):1761-9.
2011: Eric A Klein; Laurence Klotz; Michael M Lieber; Scott M Lippman; M Scott Lucia; Frank L Meyskens; Lori M Minasian; Howard L Parnes; J Kellogg Parsons; Catherine M Tangen; Ian M Thompson; Philip J Walther; Joseph L Chin; John J Crowley; Amy K Darke; Leslie G Ford; J Michael Gaziano; Gary E Goodman; Phyllis J Goodman; Daniel D Karp; Laurence H Baker
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
JAMA : the journal of the American Medical Association 2011;306(14):1549-56.
2011: Li Tang; Catherine M Tangen; Ian M Thompson; Cathee Till; Yue Wu; Song Yao; Phyllis J Goodman; Ashraful Hoque; Ann W Hsing; Alan R Kristal; Scott M Lippman; Marian L Neuhouser; Elizabeth A Platz; Juergen K V Reichardt; Regina M Santella; Frank Z Stanczyk; Christine B Ambrosone
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Carcinogenesis 2011;32(10):1500-6.
2011: Steven B Zeliadt; Judith Lee Smith; Ian M Thompson; David K Blough; Donatus U Ekwueme; Catherine R Fedorenko; Ingrid J Hall; Thomas E Keane; Carol M Moinpour; David F Penson; Scott D Ramsey
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
BJU international 2011;108(6):851-6; discussion 856-7.
2011: Emil Scosyrev; V O Speights; Catherine M Tangen; E David Crawford; Ralph W deVere White; Benjamin W Ely; H Barton Grossman; Edward M Messing; Ronald B Natale; Donald L Trump; Nicholas J Vogelzang; David P Wood; Ian M Thompson
Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).
BJU international 2011;108(5):693-9.
2011: Laurence Klotz; Ian M Thompson
Early prostate cancer--treat or watch?
The New England journal of medicine 2011;365(6):569.
2011: Chen Li; Michelle A Anderson; John M Casper; Michael C Mullenix; Diane M Simeone; Ian M Thompson; Eugene Zolotarevsky; David M Lubman
A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancer.
Electrophoresis 2011;32(15):2028-35.
2011: Song Yao; Christine B Ambrosone; William D Figg; Phyllis J Goodman; Ann W Hsing; Alan R Kristal; Scott M Lippman; Marian L Neuhouser; Howard L Parnes; Elizabeth A Platz; Douglas K Price; Juergen K V Reichardt; Regina M Santella; Frank Z Stanczyk; Li Tang; Catherine M Tangen; Ian M Thompson; Cathee Till; Ashraful Hoque
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
Cancer causes & control : CCC 2011;22(8):1121-31.
2011: Joke Beuten; Ravindranath Duggirala; Sharon P Fowler; Harald H H Groing; Indrani Halder; Robin J Leach; Rector Arya; Ian M Thompson; Donna Lehman
Wide disparity in genetic admixture among Mexican Americans from San Antonio, TX.
Annals of human genetics 2011;75(4):529-38.
2011: Donna P Ankerst; Andreas Boeck; Nidzara Dizdarevic; Sergiy Kyrylenko; Yuanyuan Liang; Brad H Pollock; Ian M Thompson; Robin J Leach
Trends and co-trends of prostate-specific antigen and body mass index in a screened population.
Urology 2011;78(1):10-6.
2011: Jeannette M Schenk; Catherine M Tangen; Emily White; Kathryn B Arnold; Alan R Kristal; Daniel W Lin; Marian L Neuhouser; Ian M Thompson
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.
American journal of epidemiology 2011;173(12):1419-28.
2011: Theodore M Brasky; Phyllis Goodman; Irena B King; Marian L Neuhouser; Xiaoling Song; Ian M Thompson; Cathee Till; Emily White; Demetrius Albanes; Alan R Kristal
Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.
American journal of epidemiology 2011;173(12):1429-39.
2011: Tanya B Dorff; Thomas W Flaig; Catherine M Tangen; Maha Hussain; Gregory Swanson; David P Wood; Wael A Sakr; Nancy A Dawson; Naomi B Haas; E David Crawford; Nicholas J Vogelzang; Ian M Thompson; L Michael Glode
Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(15):2040-5.
2011: David C Smith; Cathy M Tangen; Peter J Van Veldhuizen; Grant W Harrer; Ali Golshayan; Glenn M Mills; Nicholas J Vogelzang; Ian M Thompson; Maha Hussain
Phase II evaluation of early oral estramustine, oral etoposide, and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group S0032.
Urology 2011;77(5):1172-6.
2011: Rulon L Hardman; Fadi El-Merhi; Adam J Jung; Steve Ware; Ian M Thompson; Harry T Friel; Qi Peng
Fast T2*-weighted MRI of the prostate at 3 Tesla.
Journal of magnetic resonance imaging : JMRI 2011;33(4):902-7.
2011: Alan R Kristal; Cathee Till; Elizabeth A Platz; Xiaoling Song; Irena B King; Marian L Neuhouser; Christine B Ambrosone; Ian M Thompson
Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(4):638-46.
2011: Andrew J Vickers; Cathee Till; Catherine M Tangen; Hans Lilja; Ian M Thompson
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.
Journal of the National Cancer Institute 2011;103(6):462-9.
2011: Ian M Thompson; Robin J Leach; Donna P Ankerst
Prostate cancer detection: a view of the future.
European urology 2011;59(2):191-3.
2011: Ian M Thompson; Shady Salem; Sam S Chang; Peter E Clark; Rodney Davis; S Duke Herrell; Yakup Kordan; Roxelyn Baumgartner; Sharon Phillips; Joseph A Smith; Michael S Cookson; Daniel A Barocas
Tumor volume as a predictor of adverse pathologic features and biochemical recurrence (BCR) in radical prostatectomy specimens: a tale of two methods.
World journal of urology 2011;29(1):15-20.
2011: Scott D Ramsey; Steven B Zeliadt; Catherine R Fedorenko; David K Blough; Carol M Moinpour; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Megan E Fairweather; Ian M Thompson; Thomas E Keane; David F Penson
Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions.
World journal of urology 2011;29(1):3-9.
2011: Sun Hee Rim; Judith Lee Smith; Ian M Thompson; Steven B Zeliadt; Donatus U Ekwueme; Megan E Fairweather; Catherine R Fedorenko; Ingrid J Hall; Thomas E Keane; Carol M Moinpour; David F Penson; Scott D Ramsey
Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population.
International journal of general medicine 2011;4():481-6.
2011: Yuanyuan Liang; Donna Pauler Ankerst; Norma S Ketchum; Barbara Ercole; Girish Shah; John D Shaughnessy; Robin J Leach; Ian M Thompson
Prospective evaluation of operating characteristics of prostate cancer detection biomarkers.
The Journal of urology 2011;185(1):104-10.
2011: Bao-Li Chang; Elaine Spangler; Stephen Gallagher; Christopher A Haiman; Brian Henderson; William B Isaacs; Marnita L Benford; LaCreis R Kidd; Kathleen Cooney; Sara Strom; Sue Ann Ingles; Mariana C Stern; Roman Corral; Amit D Joshi; Jianfeng Xu; Veda N Giri; Benjamin A Rybicki; Christine Neslund-Dudas; Adam S Kibel; Ian M Thompson; Robin J Leach; Elaine A Ostrander; Janet L Stanford; John Witte; Graham Casey; Rosalind Eeles; Ann W Hsing; STEPHEN CHANOCK; Jennifer Hu; Esther M John; Jong Park; Klara Stefflova; Charnita Zeigler-Johnson; Timothy R Rebbeck
Validation of genome-wide prostate cancer associations in men of African descent.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(1):23-32.
2010: Phyllis J Goodman; Catherine M Tangen; Alan R Kristal; Ian M Thompson; M Scott Lucia; Elizabeth A Platz; William D Figg; Ashraful Hoque; Ann W Hsing; Marian L Neuhouser; Howard L Parnes; Juergen K V Reichardt; Regina M Santella; Cathee Till; Scott M Lippman
Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.
Cancer prevention research (Philadelphia, Pa.) 2010;3(12):1523-33.
2010: Ian M Thompson; Laurence Klotz
Active surveillance for prostate cancer.
JAMA : the journal of the American Medical Association 2010;304(21):2411-2.
2010: Douglas K Price; Cindy H Chau; Cathee Till; Phyllis J Goodman; Caitlin E Baum; Sandy B Ockers; Bevin C English; Lori M Minasian; Howard L Parnes; Ann W Hsing; Juergen K V Reichardt; Ashraful Hoque; Catherine M Tangen; Alan R Kristal; Ian M Thompson; William D Figg
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial.
The Journal of urology 2010;184(6):2297-302.
2010: Yuanyuan Liang; Donna Pauler Ankerst; Michael Sanchez; Robin J Leach; Ian M Thompson
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
Urology 2010;76(5):1268.e1-6.
2010: Ian M Thompson; Donna Pauler Ankerst; Catherine M Tangen
Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma.
Journal of the National Cancer Institute 2010;102(17):1299-301.
2010: Alan R Kristal; Kathryn B Arnold; Marian L Neuhouser; Phyllis Goodman; Elizabeth A Platz; Demetrius Albanes; Ian M Thompson
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.
American journal of epidemiology 2010;172(5):566-77.
2010: Tanya B Dorff; Bryan Goldman; Jacek Pinski; Philip C Mack; Primo Lara; Peter J Van Veldhuizen; David I Quinn; Nicholas J Vogelzang; Ian M Thompson; Maha Hussain
Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(11):3028-34.
2010: Laura Esserman; Ian M Thompson
Solving the overdiagnosis dilemma.
Journal of the National Cancer Institute 2010;102(9):582-3.
2010: Steven B Zeliadt; Carol M Moinpour; David K Blough; David F Penson; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Ian M Thompson; Thomas E Keane; Scott D Ramsey
Preliminary treatment considerations among men with newly diagnosed prostate cancer.
The American journal of managed care 2010;16(5):e121-30.
2010: Lori J Sokoll; Martin G Sanda; Ziding Feng; Jacob Kagan; Isaac A Mizrahi; Dennis L Broyles; Alan W Partin; Sudhir Srivastava; Ian M Thompson; John T Wei; Zhen Zhang; Daniel W Chan
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(5):1193-200.
2010: Addanki Kumar; Heather Graham; Craig Robson; Ian M Thompson; Rita Ghosh
Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer management.
Mini reviews in medicinal chemistry 2010;10(5):388-97.
2010: Alan R Kristal; Douglas K Price; Cathee Till; Jeannette M Schenk; Marian L Neuhouser; Sandy Ockers; Daniel W Lin; Ian M Thompson; William D Figg
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
The Prostate 2010;70(6):584-90.
2010: Ashraful Hoque; Christine B Ambrosone; Cathee Till; Phyllis J Goodman; Cathy Tangen; Alan Kristal; Scott Lucia; Qiao Wang; Maya Kappil; Ian M Thompson; Ann W Hsing; Howard Parnes; Regina M Santella
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial.
Cancer prevention research (Philadelphia, Pa.) 2010;3(4):478-83.
2010: Ian M Thompson
Editorial comment.
Urology 2010;75(3):509-10.
2010: Andrew M D Wolf; Richard C Wender; Ruth B Etzioni; Ian M Thompson; Anthony V D'Amico; Robert J Volk; Durado D Brooks; Chiranjeev Dash; Idris Guessous; Kimberly Andrews; Carol DeSantis; Robert A Smith
American Cancer Society guideline for the early detection of prostate cancer: update 2010.
CA: a cancer journal for clinicians 2010;60(2):70-98.
2010: Jeannette M Schenk; Alan R Kristal; Marian L Neuhouser; Catherine M Tangen; Emily White; Daniel W Lin; Mario Kratz; Ian M Thompson
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
American journal of epidemiology 2010;171(5):571-82.
2010: Siobhan Sutcliffe; Raphael P Viscidi; Cathee Till; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; Jonathan M Zenilman; Angelo M DeMarzo; Elizabeth A Platz
Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(2):614-8.
2010: Joke Beuten; Jonathan Gelfond; Jennifer L Franke; Stacey Shook; Teresa Johnson-Pais; Ian M Thompson; Robin J Leach
Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(2):588-99.
2010: Lisa F Newcomb; James D Brooks; Peter R Carroll; Ziding Feng; Martin E Gleave; Peter S Nelson; Ian M Thompson; Daniel W Lin
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.
Urology 2010;75(2):407-13.
2010: Joel M H Teichman; Jason Sea; Ian M Thompson; Dirk M Elston
Noninfectious penile lesions.
American family physician 2010;81(2):167-74.
2009: Stephen J Eyre; Donna P Ankerst; John T Wei; Prakash V Nair; Meredith M Regan; Gerrardina Bueti; Jeffrey Tang; Mark A Rubin; Michael Kearney; Ian M Thompson; Martin G Sanda
Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection.
The Journal of urology 2009;182(6):2653-8.
2009: Catherine M Tangen; Bryan H Goldman; Gregory Swanson; Ian M Thompson
Biased hormonal therapy duration analysis makes results uninterpretable.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):e203; author reply e204.
2009: Elizabeth A Platz; Cathee Till; Phyllis J Goodman; Howard L Parnes; William D Figg; Demetrius Albanes; Marian L Neuhouser; Eric A Klein; Ian M Thompson; Alan R Kristal
Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):2807-13.
2009: Laura Esserman; Yiwey Shieh; Ian M Thompson
Rethinking screening for breast cancer and prostate cancer.
JAMA : the journal of the American Medical Association 2009;302(15):1685-92.
2009: Joke Beuten; Dawn Garcia; Timothy C Brand; Xin He; Ivana Balic; Edith Canby-Hagino; Dean A Troyer; Jacques Baillargeon; Javier Hernandez; Ian M Thompson; Robin J Leach; Susan Naylor
Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.
The Journal of urology 2009;182(4):1614-20.
2009: Jamey A Sarvis; Ian M Thompson
United States military contributions to the National Cancer Institute.
Urologic oncology 2009;27(5):558-61.
2009: Jeannette M Schenk; Alan R Kristal; Marian L Neuhouser; Catherine M Tangen; Emily White; Daniel W Lin; Ian M Thompson
Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
The Prostate 2009;69(12):1303-11.
2009: Zhihong Gong; Alan R Kristal; Jeannette M Schenk; Catherine M Tangen; Phyllis J Goodman; Ian M Thompson
Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Cancer 2009;115(16):3661-9.
2009: Joke Beuten; Jonathan Gelfond; Margarita L Martinez-Fierro; Korri S Weldon; AnaLisa C Crandall; Augusto Rojas-Martinez; Ian M Thompson; Robin J Leach
Association of chromosome 8q variants with prostate cancer risk in Caucasian and Hispanic men.
Carcinogenesis 2009;30(8):1372-9.
2009: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Eric A Klein
Chemoprevention of prostate cancer.
The Journal of urology 2009;182(2):499-507; discussion 508.
2009: Otis W Brawley; Donna P Ankerst; Ian M Thompson
Screening for prostate cancer.
CA: a cancer journal for clinicians 2009;59(4):264-73.
2009: Ian M Thompson; Catherine M Tangen; Eric A Klein
Is there a standard of care for pathologic stage T3 prostate cancer?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2898-9.
2009: Joke Beuten; Jonathan Gelfond; Jennifer L Franke; Korri S Weldon; Analisa C Crandall; Teresa Johnson-Pais; Ian M Thompson; Robin J Leach
Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(6):1869-80.
2009: Donna Pauler Ankerst; Ryan Miyamoto; Prakash Vijay Nair; Bradley Pollock; Ian M Thompson; Dipen J Parekh
Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population.
The Journal of urology 2009;181(5):2071-5; discussion 2076.
2009: Roger S Rittmaster; Neil E Fleshner; Ian M Thompson
Pharmacological approaches to reducing the risk of prostate cancer.
European urology 2009;55(5):1064-73.
2009: Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean A Troyer; Edward Messing; Jeffrey Forman; Joseph Chin; Gregory Swanson; Edith D Canby-Hagino; E David Crawford
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.
The Journal of urology 2009;181(3):956-62.
2009: Kyoungmi Kim; Pavel Aronov; Stanislav O Zakharkin; Danielle Anderson; Bertrand Perroud; Ian M Thompson; Robert H Weiss
Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
Molecular & cellular proteomics : MCP 2009;8(3):558-70.
2009: Christina Wang; Eberhard Nieschlag; Ronald S Swerdloff; Hermann Behre; Wayne J Hellstrom; Louis J Gooren; Jean M Kaufman; Jean-Jacques Legros; Bruno Lunenfeld; Alvaro Morales; John E Morley; Claude Schulman; Ian M Thompson; Wolfgang Weidner; Frederick C W Wu
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.
The aging male : the official journal of the International Society for the Study of the Aging Male 2009;12(1):5-12.
2009: Chen-Pin Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; Ian M Thompson; W Weidner; F C W Wu
Investigation, treatment and monitoring of late-onset hypogonadism in males.
International journal of andrology 2009;32(1):1-10.
2009: Scott M Lippman; Eric A Klein; Phyllis J Goodman; M Scott Lucia; Ian M Thompson; Leslie G Ford; Howard L Parnes; Lori M Minasian; J Michael Gaziano; Jo Ann Hartline; J Kellogg Parsons; James Bearden; E David Crawford; Gary E Goodman; Jaime Claudio; Eric Winquist; Elise D Cook; Daniel D Karp; Philip Walther; Michael M Lieber; Alan R Kristal; Amy K Darke; Kathryn B Arnold; Patricia Anne Ganz; Regina M Santella; Demetrius Albanes; Philip R Taylor; Jeffrey L Probstfield; T J Jagpal; John J Crowley; Frank L Meyskens; Laurence H Baker; Charles A Coltman
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
JAMA : the journal of the American Medical Association 2009;301(1):39-51.
2009: Christina Wang; E Nieschlag; Ronald S Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; Ian M Thompson; W Weidner; F C W Wu
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.
International journal of impotence research 2009;21(1):1-8.
2009: Christina Wang; E Nieschlag; Ronald S Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; Ian M Thompson; W Weidner; F C W Wu
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.
Journal of andrology 2009;30(1):1-9.
2009: Christina Wang; Eberhard Nieschlag; Ronald Swerdloff; Hermann M Behre; Wayne J Hellstrom; Louis J Gooren; Jean M Kaufman; Jean-Jacques Legros; Bruno Lunenfeld; Alvaro Morales; John E Morley; Claude Schulman; Ian M Thompson; Wolfgang Weidner; Frederick C W Wu
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.
European urology 2009;55(1):121-30.
2008: Alan R Kristal; Jeannette M Schenk; YoonJu Song; Kathryn B Arnold; Marian L Neuhouser; Phyllis J Goodman; Daniel W Lin; Frank Z Stanczyk; Ian M Thompson
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
American journal of epidemiology 2008;168(12):1416-24.
2008: Gregory Swanson; Bryan Goldman; Catherine M Tangen; Joseph Chin; Edward Messing; Edith D Canby-Hagino; Jeffrey D Forman; Ian M Thompson; E David Crawford
The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794.
The Journal of urology 2008;180(6):2453-7; discussion 2458.
2008: Ian M Thompson; Catherine M Tangen; Alan R Kristal
Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Journal of the National Cancer Institute 2008;100(21):1487-8.
2008: Christina Wang; E Nieschlag; Ronald S Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; Ian M Thompson; W Weidner; F C W Wu
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(5):507-14.
2008: Jamey A Sarvis; Ian M Thompson
Prostate cancer chemoprevention: update of the prostate cancer prevention trial findings and implications for clinical practice.
Current oncology reports 2008;10(6):529-32.
2008: Donna Pauler Ankerst; Jack Groskopf; John R Day; Amy Blase; Harry Rittenhouse; Bradley Pollock; Catherine M Tangen; Dipen J Parekh; Robin J Leach; Ian M Thompson
Predicting prostate cancer risk through incorporation of prostate cancer gene 3.
The Journal of urology 2008;180(4):1303-8; discussion 1308.
2008: Ian M Thompson; Donna Pauler Ankerst; Ruth Etzioni; Thomas D Wang
It's time to abandon an upper limit of normal for prostate specific antigen: assessing the risk of prostate cancer.
The Journal of urology 2008;180(4):1219-22.
2008: Marian L Neuhouser; Jeannette Schenk; Yoon Ju Song; Catherine M Tangen; Phyllis J Goodman; Michael Pollak; David F Penson; Ian M Thompson; Alan R Kristal
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial.
The Prostate 2008;68(13):1477-86.
2008: Joke Beuten; Jonathan Gelfond; John J Byrne; Ivana Balic; AnaLisa C Crandall; Teresa Johnson-Pais; Ian M Thompson; Douglas K Price; Robin J Leach
CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians.
Carcinogenesis 2008;29(9):1751-7.
2008: Mary W Redman; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Charles A Coltman; Ian M Thompson
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.
Cancer prevention research (Philadelphia, Pa.) 2008;1(3):174-81.
2008: M Scott Lucia; Amy K Darke; Phyllis J Goodman; Francisco G La Rosa; Howard L Parnes; Leslie G Ford; Charles A Coltman; Ian M Thompson
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.
Cancer prevention research (Philadelphia, Pa.) 2008;1(3):167-73.
2008: Amanda Beth Reed; Donna Pauler Ankerst; Robin J Leach; Gilbert Vipraio; Ian M Thompson; Dipen J Parekh
Total prostate specific antigen stability confirmed after long-term storage of serum at -80C.
The Journal of urology 2008;180(2):534-7; discussion 537-8.
2008: Lori J Sokoll; Yinghui Wang; Ziding Feng; Jacob Kagan; Alan W Partin; Martin G Sanda; Ian M Thompson; Daniel W Chan
[-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study.
The Journal of urology 2008;180(2):539-43; discussion 543.
2008: Ian M Thompson; Catherine M Tangen; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis Goodman; Howard L Parnes; Charles A Coltman
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy.
The Journal of urology 2008;180(2):544-7.
2008: Jamey A Sarvis; Ian M Thompson
Androgens and prevention of prostate cancer.
Current opinion in endocrinology, diabetes, and obesity 2008;15(3):271-7.
2008: Dean A Troyer; Y Tang; R Bedolla; Siddharth Adhvaryu; Ian M Thompson; S Abboud-Werner; Luzhe Sun; W E Friedrichs; Linda A de Graffenried
Characterization of PacMetUT1, a recently isolated human prostate cancer cell line.
The Prostate 2008;68(8):883-92.
2008: Kathleen C Torkko; Adrie van Bokhoven; Phoung Mai; Joke Beuten; Ivana Balic; Tim E Byers; John E Hokanson; Jill M Norris; Anna E Barón; M Scott Lucia; Ian M Thompson; Robin J Leach
VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(10):3223-9.
2008: Ian M Thompson; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Charles A Coltman
Does the level of prostate cancer risk affect cancer prevention with finasteride?
Urology 2008;71(5):854-7.
2008: Alan R Kristal; Kathryn B Arnold; Jeannette M Schenk; Marian L Neuhouser; Phyllis Goodman; David F Penson; Ian M Thompson
Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
American journal of epidemiology 2008;167(8):925-34.
2008: Ian M Thompson; Catherine M Tangen; M Scott Lucia
The Prostate Cancer Prevention Trial and the future of chemoprevention.
BJU international 2008;101(8):933-4.
2008: YoonJu Song; Catherine M Tangen; Phyllis Goodman; Howard L Parnes; M Scott Lucia; Ian M Thompson; Alan R Kristal
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.
The Prostate 2008;68(3):281-6.
2008: Timothy C Brand; Carlos Bermejo; Edith D Canby-Hagino; Dean A Troyer; Jacques Baillargeon; Ian M Thompson; Robin J Leach; Susan Naylor
Association of polymorphisms in TGFB1 and prostate cancer prognosis.
The Journal of urology 2008;179(2):754-8.
2008: Margaret Sullivan Pepe; Ziding Feng; Ying Huang; Gary Longton; Ross L Prentice; Ian M Thompson; Yingye Zheng
Integrating the predictiveness of a marker with its performance as a classifier.
American journal of epidemiology 2008;167(3):362-8.
2008: Elisabeth Iljas Heath; Michael W Kattan; Isaac J Powell; Wael A Sakr; Timothy C Brand; Benjamin A Rybicki; Ian M Thompson; William J Aronson; Martha Kennedy Terris; Christopher J Kane; Joseph C Presti; Christopher L Amling; Stephen J Freedland
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.
Urology 2008;71(1):151-5.
2008: Carol M Moinpour; Katherine A Hayden; Joseph M Unger; Ian M Thompson; Mary W Redman; Edith D Canby-Hagino; Betsy A Higgins; Jerry W Sullivan; Dianne Lemmon; Sheila Breslin; E David Crawford
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(1):112-20.
2008: Dale McLerran; William E Grizzle; Ziding Feng; Ian M Thompson; William L Bigbee; Lisa H Cazares; Daniel W Chan; Jackie Dahlgren; Jose Diaz; Jacob Kagan; Daniel W Lin; Gunjan Malik; Denise Oelschlager; Alan W Partin; Timothy W Randolph; Lori J Sokoll; sudhir srivastava; Sudhir Srivastava; Mark D Thornquist; Dean A Troyer; George L Wright; Zhen Zhang; Liu Zhu; O John Semmes
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer.
Clinical chemistry 2008;54(1):53-60.
2008: Dale McLerran; William E Grizzle; Ziding Feng; William L Bigbee; Lionel L Banez; Lisa H Cazares; Daniel W Chan; Jose Diaz; Elzbieta Izbicka; Jacob Kagan; David E Malehorn; Gunjan Malik; Denise Oelschlager; Alan W Partin; Timothy W Randolph; Nicole Rosenzweig; sudhir srivastava; Sudhir Srivastava; Ian M Thompson; Mark D Thornquist; Dean A Troyer; Yutaka Yasui; Zhen Zhang; Liu Zhu; O John Semmes
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.
Clinical chemistry 2008;54(1):44-52.
2007: Dipen J Parekh; Donna Pauler Ankerst; Dean A Troyer; sudhir srivastava; Ian M Thompson
Biomarkers for prostate cancer detection.
The Journal of urology 2007;178(6):2252-9.
2007: Gregory Swanson; Ian M Thompson
Adjuvant radiotherapy for high-risk patients following radical prostatectomy.
Urologic oncology 2007;25(6):515-9.
2007: Rita Ghosh; Gretchen E Garcia; Katherine Crosby; Hiroyasu Inoue; Ian M Thompson; Dean A Troyer; Addanki Kumar
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.
Neoplasia (New York, N.Y.) 2007;9(11):893-9.
2007: Amanda Reed; Donna Pauler Ankerst; Bradley Pollock; Ian M Thompson; Dipen J Parekh
Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.
The Journal of urology 2007;178(5):1929-32; discussion 1932.
2007: Ruth Etzioni; Donna Pauler Ankerst; Noel S Weiss; Lurdes Y T Inoue; Ian M Thompson
Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.
Journal of the National Cancer Institute 2007;99(20):1510-5.
2007: Edith D Canby-Hagino; Javier Hernandez; Timothy C Brand; Dean A Troyer; Betsy Higgins; Donna Pauler Ankerst; Ian M Thompson; Robin J Leach; Dipen J Parekh
Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
Urology 2007;70(4):748-52.
2007: Dipen J Parekh; Donna Pauler Ankerst; Jacques Baillargeon; Betsy Higgins; Elizabeth A Platz; Dean A Troyer; Javier Hernandez; Robin J Leach; Anna Lokshin; Ian M Thompson
Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(10):1966-72.
2007: Stacie J Shook; Joke Beuten; Kathleen C Torkko; Teresa Johnson-Pais; Dean A Troyer; Ian M Thompson; Robin J Leach
Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5959-64.
2007: M Scott Lucia; Jonathan I Epstein; Phyllis J Goodman; Amy K Darke; Victor E Reuter; Francisco Civantos; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Francisco G La Rosa; Michael W Kattan; E David Crawford; Leslie G Ford; Charles A Coltman; Ian M Thompson
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(18):1375-83.
2007: Philip W Kantoff; Tomasz M Beer; Anthony V D'Amico; Robert S Dipaola; Mario A Eisenberger; Maha Hussain; W Kevin Kelly; Paul Mathew; Michael J Morris; Charles J Ryan; Howard M Sandler; Ian M Thompson; Peter R Carroll
Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference.
The Journal of urology 2007;178(3 Pt 2):S5-8; quiz S4.
2007: Ian M Thompson
Chemoprevention of prostate cancer: agents and study designs.
The Journal of urology 2007;178(3 Pt 2):S9-S13.
2007: Arthur L Burnett; Gunnar Aus; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen Kraus; Monica Liebert; Judd W Moul; Catherine Tangen; J Brantley Thrasher; Ian M Thompson
Erectile function outcome reporting after clinically localized prostate cancer treatment.
The Journal of urology 2007;178(2):597-601.
2007: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3076-81.
2007: Carol M Moinpour; Amy K Darke; Gary W Donaldson; Ian M Thompson; Connie Langley; Donna Pauler Ankerst; Donald L Patrick; John Ware; Patricia Anne Ganz; Sally A Shumaker; Scott M Lippman; Charles A Coltman
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(13):1025-35.
2007: Gregory Swanson; William R Carpenter; Ian M Thompson; E David Crawford
Urologists' attitudes regarding cancer clinical research.
Urology 2007;70(1):19-24.
2007: Ian M Thompson
Chemoprevention of prostate cancer: lessons learned.
BJU international 2007;100 Suppl 2():15-7.
2007: E David Crawford; Ian M Thompson
Controversies regarding screening for prostate cancer.
BJU international 2007;100 Suppl 2():5-7.
2007: Ian M Thompson; M Scott Lucia; Mary W Redman; Amy K Darke; Francisco G La Rosa; Howard L Parnes; Scott M Lippman; Charles A Coltman
Finasteride decreases the risk of prostatic intraepithelial neoplasia.
The Journal of urology 2007;178(1):107-9; discussion 110.
2007: Ian M Thompson; Donna Pauler Ankerst
Prostate-specific antigen in the early detection of prostate cancer.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2007;176(13):1853-8.
2007: Gregory Swanson; Michael A Hussey; Catherine M Tangen; Joseph Chin; Edward Messing; Edith D Canby-Hagino; Jeffrey D Forman; Ian M Thompson; E David Crawford
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2225-9.
2007: Ian M Thompson; J Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen Kraus; Judd W Moul; Catherine Tangen
Guideline for the management of clinically localized prostate cancer: 2007 update.
The Journal of urology 2007;177(6):2106-31.
2007: Timothy C Brand; Edith D Canby-Hagino; Ian M Thompson
Testosterone replacement therapy and prostate cancer: a word of caution.
Current urology reports 2007;8(3):185-9.
2007: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Howard L Parnes; Scott M Lippman; Charles A Coltman
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
The Journal of urology 2007;177(5):1749-52.
2007: Dipen J Parekh; Donna Pauler Ankerst; Ian M Thompson
Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies.
Journal of the National Cancer Institute 2007;99(7):496-7.
2007: Ian M Thompson; M Scott Lucia; Catherine M Tangen
Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9.
International journal of epidemiology 2007;36(2):287-9.
2007: Alayne D Markland; Ian M Thompson; Donna Pauler Ankerst; Betsy Higgins; Stephen Kraus
Lack of disparity in lower urinary tract symptom severity between community-dwelling non-Hispanic white, Mexican-American, and African-American men.
Urology 2007;69(4):697-702.
2007: Alan R Kristal; Kathryn B Arnold; Jeannette M Schenk; Marian L Neuhouser; Noel Weiss; Phyllis Goodman; Colleen M Antvelink; David F Penson; Ian M Thompson
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
The Journal of urology 2007;177(4):1395-400; quiz 1591.
2007: Rhonda M Walsh; Ian M Thompson
Prostate cancer screening and disease management: how screening may have an unintended effect on survival and mortality-the camel's nose effect.
The Journal of urology 2007;177(4):1303-6.
2007: Ruth Etzioni; Donna Pauler Ankerst; Ian M Thompson
Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.
Journal of the National Cancer Institute 2007;99(6):489-90; author reply 490.
2007: Michael S Cookson; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen Kraus; Judd W Moul; Catherine Tangen; J Brantley Thrasher; Ian M Thompson
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
The Journal of urology 2007;177(2):540-5.
2007: Donna Pauler Ankerst; Ian M Thompson
Understanding mixed messages about prostate specific antigen: biases in the evaluation of cancer biomarkers.
The Journal of urology 2007;177(2):426-7.
2007: Mack Roach; Vivian Weinberg; Howard Sandler; Ian M Thompson
Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
Cancer 2007;109(2):213-20.
2007: Edith D Canby-Hagino; Javier Hernandez; Timothy C Brand; Ian M Thompson
Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention.
European urology 2007;51(1):27-33.
2006: Donna Pauler Ankerst; Ian M Thompson
New answers from the Prostate Cancer Prevention Trial on the chemoprevention of prostate cancer.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2006;78(4):154-6.
2006: Donna Pauler Ankerst; Ian M Thompson
Merging digital rectal exam, family history, age and prostate-specific antigen to create a decision-making tool.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2006;78(4):143-6.
2006: Donna Pauler Ankerst; Ian M Thompson
Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 2006;78(4):125-9.
2006: Dipen J Parekh; Donna Pauler Ankerst; Betsy A Higgins; Javier Hernandez; Edith D Canby-Hagino; Timothy C Brand; Dean A Troyer; Robin J Leach; Ian M Thompson
External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.
Urology 2006;68(6):1152-5.
2006: Ian M Thompson; Peter R Carroll; Michael A Carducci
Recommendations for defining and treating high risk localized prostate cancer.
The Journal of urology 2006;176(6 Pt 2):S6-S10; quiz S3-5.
2006: Ian M Thompson
Defining high risk prostate cancer--where do we set the bar? A translational science approach to risk stratification.
The Journal of urology 2006;176(6 Pt 2):S21-4; discussion S25-6.
2006: Timothy J Wilt; Ian M Thompson
Clinically localised prostate cancer.
BMJ (Clinical research ed.) 2006;333(7578):1102-6.
2006: Ian M Thompson; Catherine M Tangen; Jorge Paradelo; M Scott Lucia; Gary Miller; Dean A Troyer; Edward Messing; Jeffrey D Forman; Joseph Chin; Gregory Swanson; Edith D Canby-Hagino; E David Crawford
Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.
JAMA : the journal of the American Medical Association 2006;296(19):2329-35.
2006: Zhihong Gong; Marian L Neuhouser; Phyllis J Goodman; Demetrius Albanes; Chen Chi; Ann W Hsing; Scott M Lippman; Elizabeth A Platz; Michael N Pollak; Ian M Thompson; Alan R Kristal
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(10):1977-83.
2006: Ian M Thompson
PSA: a biomarker for disease. A biomarker for clinical trials. How useful is it?
The Journal of nutrition 2006;136(10):2704S.
2006: Gregory Swanson; Ian M Thompson; Joseph W Basler; E David Crawford
Metastatic prostate cancer-does treatment of the primary tumor matter?
The Journal of urology 2006;176(4 Pt 1):1292-8.
2006: Ian M Thompson; Chen Chi; Donna Pauler Ankerst; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
Journal of the National Cancer Institute 2006;98(16):1128-33.
2006: James R Marshall; Wael A Sakr; David P Wood Jr; Donna Berry; Catherine Tangen; Felicia Parker; Ian M Thompson; Scott M Lippman; Ronald Lieberman; David Alberts; David Jarrard; Charles Coltman; Peter Greenwald; Lori Minasian; E David Crawford
Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(8):1479-84.
2006: Timothy C Brand; Edith D Canby-Hagino; A Pratap Kumar; Rita Ghosh; Robin J Leach; Ian M Thompson
Chemoprevention of prostate cancer.
Hematology/oncology clinics of North America 2006;20(4):831-43.
2006: Gregory Swanson; James Faulkner; Stephen R Smalley; Mark J Noble; Ronald L Stephens; Timothy J O'Rourke; Geoffrey R Weiss; Donald P Quick; Ian M Thompson; E David Crawford
Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group Study 9024.
The Journal of urology 2006;176(2):548-53; discussion 553.
2006: Gregory Swanson; Ian M Thompson; Joseph W Basler
Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome.
Cancer 2006;107(3):439-50.
2006: Jacques Baillargeon; Elizabeth A Platz; David P Rose; Bradley Pollock; Donna Pauler Ankerst; Steven M Haffner; Betsy Higgins; Anna Lokshin; Dean A Troyer; Javier Hernandez; Steve Lynch; Robin J Leach; Ian M Thompson
Obesity, adipokines, and prostate cancer in a prospective population-based study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(7):1331-5.
2006: Gregory Swanson; Ian M Thompson; Joseph W Basler
Treatment options in lymph node-positive prostate cancer.
Cancer 2006;106(12):2531-9.
2006: Ian M Thompson; Catherine M Tangen
Does prostate volume affect accurate grading of prostate biopsies?
Nature clinical practice. Urology 2006;3(6):298-9.
2006: Phyllis J Goodman; Ian M Thompson; Catherine M Tangen; John J Crowley; Leslie G Ford; Charles A Coltman
The prostate cancer prevention trial: design, biases and interpretation of study results.
The Journal of urology 2006;175(6):2234-42.
2006: Edith D Canby-Hagino; Timothy C Brand; Javier Hernandez; Ian M Thompson
Chemoprevention of prostate cancer with finasteride.
Expert opinion on pharmacotherapy 2006;7(7):899-905.
2006: Timothy C Brand; Javier Hernandez; Edith D Canby-Hagino; Joseph W Basler; Ian M Thompson
Prostate cancer detection strategies.
Current urology reports 2006;7(3):181-5.
2006: Ian M Thompson; M Scott Lucia
Diagnosing prostate cancer: through a glass, darkly.
The Journal of urology 2006;175(5):1598-9.
2006: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2006;98(8):529-34.
2006: Sapna Vijayakumar; Devon C Hall; Xavier T Reveles; Dean A Troyer; Ian M Thompson; Dawn Garcia; Ruihua Xiang; Robin J Leach; Teresa Johnson-Pais; Susan Naylor
Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.
Cancer research 2006;66(8):4055-64.
2006: Anita L Sabichi; J Jack Lee; Robert J Taylor; Ian M Thompson; Brian J Miles; Catherine M Tangen; Lori M Minasian; Louis L Pisters; John R Caton; Joseph W Basler; Seth P Lerner; David G Menter; James R Marshall; E David Crawford; Scott M Lippman
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2178-84.
2006: Javier Hernández; Ivana Balic; Teresa Johnson-Pais; Betsy A Higgins; Kathleen C Torkko; Ian M Thompson; Robin J Leach
Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men.
The Journal of urology 2006;175(2):523-7.
2006: Alan R Kristal; Chen Chi; Catherine M Tangen; Phyllis J Goodman; Ruth Etzioni; Ian M Thompson
Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.
Cancer 2006;106(2):320-8.
2006: Steven J Hudak; Javier Hernandez; Ian M Thompson
Role of 5 alpha-reductase inhibitors in the management of prostate cancer.
Clinical interventions in aging 2006;1(4):425-31.
2005: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Erectile dysfunction and subsequent cardiovascular disease.
JAMA : the journal of the American Medical Association 2005;294(23):2996-3002.
2005: Ian M Thompson; Catherine M Tangen; Eric A Klein; Scott M Lippman
Phase III prostate cancer prevention trials: are the costs justified?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(32):8161-4.
2005: Eric A Klein; Catherine M Tangen; Phyllis J Goodman; Scott M Lippman; Ian M Thompson
Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7460-6.
2005: Ian M Thompson; Carlos Bermejo; Javier Hernandez; Joseph W Basler; Edith D Canby-Hagino
Screening for prostate cancer: opportunities and challenges.
Surgical oncology clinics of North America 2005;14(4):747-60.
2005: Ian M Thompson; Edith D Canby-Hagino; M Scott Lucia
Stage migration and grade inflation in prostate cancer: Will Rogers meets Garrison Keillor.
Journal of the National Cancer Institute 2005;97(17):1236-7.
2005: Ian M Thompson; Donald R Bohay; John G Anderson
Fusion rate of first tarsometatarsal arthrodesis in the modified Lapidus procedure and flatfoot reconstruction.
Foot & ankle international. / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society 2005;26(9):698-703.
2005: Ruth Etzioni; Nadia Howlader; Pamela A Shaw; Donna Pauler Ankerst; David F Penson; Phyllis J Goodman; Ian M Thompson
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
The Journal of urology 2005;174(3):877-81.
2005: Steven B Zeliadt; Ruth Etzioni; David F Penson; Ian M Thompson; Scott D Ramsey
Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
The American journal of medicine 2005;118(8):850-7.
2005: Kadee E Thompson; Javier Hernández; Edith D Canby-Hagino; Dean A Troyer; Ian M Thompson
Prognostic features in men who died of prostate cancer.
The Journal of urology 2005;174(2):553-6; discussion 556.
2005: Javier Hernáandez; Samira Syed; Geoffrey Weiss; Gabriel Fernandes; Dendra von Merveldt; Dean A Troyer; Joseph W Basler; Ian M Thompson
The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
The Journal of urology 2005;174(2):519-22.
2005: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
JAMA : the journal of the American Medical Association 2005;294(1):66-70.
2005: Anthony W Tolcher; Kim Chi; John Kuhn; Martin Gleave; Amita Patnaik; Chris H Takimoto; Garry Schwartz; Ian M Thompson; Kristin Berg; Susan D'Aloisio; Nevin Murray; Stanley R Frankel; Elzbieta Izbicka; Eric K Rowinsky
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3854-61.
2005: Edith D Canby-Hagino; Ian M Thompson
Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practice.
Nature clinical practice. Oncology 2005;2(5):255-61.
2005: Robert S Dipaola; Ian M Thompson
National cooperative group trials.
Urology 2005;65(5 Suppl):23-9; discussion 29.
2005: Edith D Canby-Hagino; Gregory Swanson; E David Crawford; Joseph W Basler; Javier Hernandez; Ian M Thompson
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?
Current urology reports 2005;6(3):183-9.
2005: Kanwaljit Mahal; Javier Hernandez; Joseph W Basler; Ian M Thompson
What's new in the field of prostate cancer chemoprevention?
Current urology reports 2005;6(3):177-82.
2005: Javier Hernandez; Edith D Canby-Hagino; Ian M Thompson
Biomarkers for the detection and prognosis of prostate cancer.
Current urology reports 2005;6(3):171-6.
2005: Javier Hernandez; Ian M Thompson
Carcinoma core distribution in patients with palpable and nonpalpable prostate tumors.
Cancer 2005;103(9):1761-2.
2005: Michael B Williams; Javier Hernandez; Ian M Thompson
Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength.
The Journal of urology 2005;173(4):1067-71.
2005: Joseph M Unger; Ian M Thompson; Michael LeBlanc; John J Crowley; Phyllis J Goodman; Leslie G Ford; Charles A Coltman
Estimated impact of the Prostate Cancer Prevention Trial on population mortality.
Cancer 2005;103(7):1375-80.
2005: Jacques Baillargeon; Bradley Pollock; Alan R Kristal; Patrick Bradshaw; Javier Hernandez; Joseph W Basler; Betsy Higgins; Steve Lynch; Thomas Rozanski; Dean A Troyer; Ian M Thompson
The association of body mass index and prostate-specific antigen in a population-based study.
Cancer 2005;103(5):1092-5.
2005: Scott M Lippman; Phyllis J Goodman; Eric A Klein; Howard L Parnes; Ian M Thompson; Alan R Kristal; Regina M Santella; Jeffrey L Probstfield; Carol M Moinpour; Demetrius Albanes; Philip R Taylor; Lori M Minasian; Ashraful Hoque; Sarah Moody Thomas; John J Crowley; J Michael Gaziano; Janet L Stanford; Elise D Cook; Neil E Fleshner; Michael M Lieber; Philip J Walther; Fadlo R Khuri; Daniel D Karp; Gary G Schwartz; Leslie G Ford; Charles A Coltman
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Journal of the National Cancer Institute 2005;97(2):94-102.
2005: Howard L Parnes; Ian M Thompson; Leslie G Ford
Prevention of hormone-related cancers: prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(2):368-77.
2005: O John Semmes; Ziding Feng; Bao-Ling Adam; Lionel L Banez; William L Bigbee; David Campos; Lisa H Cazares; Daniel W Chan; William E Grizzle; Elzbieta Izbicka; Jacob Kagan; Gunjan Malik; Dale McLerran; Judd W Moul; Alan W Partin; Premkala Prasanna; Jason Rosenzweig; Lori J Sokoll; sudhir srivastava; Sudhir Srivastava; Ian M Thompson; Manda J Welsh; Nicole White; Marcy Winget; Yutaka Yasui; Zhen Zhang; Liu Zhu
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
Clinical chemistry 2005;51(1):102-12.
2004: Tomasz M Beer; Catherine M Tangen; Lisa B Bland; Ian M Thompson; E David Crawford
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894.
The Journal of urology 2004;172(6 Pt 1):2213-7.
2004: Carlos Bermejo; Alan R Kristal; Steven B Zeliadt; Scott Ramsey; Ian M Thompson
Localized prostate cancer: quality of life meets Whitmore's legacy.
Journal of the National Cancer Institute 2004;96(18):1348-9.
2004: Javier Hernández; Ian M Thompson
Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.
Cancer 2004;101(5):894-904.
2004: Anthony W Tolcher; John Kuhn; Garry Schwartz; Amita Patnaik; Lisa A Hammond; Ian M Thompson; Howard Fingert; David Bushnell; Shazli Malik; Jeffrey I Kreisberg; Elzbieta Izbicka; Leslie Ann Smetzer; Eric K Rowinsky
A Phase I pharmacokinetic and biological correlative study of oblimersen sodium (genasense, g3139), an antisense oligonucleotide to the bcl-2 mRNA, and of docetaxel in patients with hormone-refractory prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5048-57.
2004: Joseph M Unger; Michael LeBlanc; Ian M Thompson; Charles A Coltman
The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies.
Urologic oncology 2004;22(4):362-8.
2004: William E Grizzle; O John Semmes; Joseph W Basler; Elzbieta Izbicka; Ziding Feng; Jacob Kagan; Bao-Ling Adam; Dean A Troyer; sudhir srivastava; Mark D Thornquist; Zhen Zhang; Ian M Thompson
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.
Urologic oncology 2004;22(4):337-43.
2004: J Curtis Nickel; Ian M Thompson
Re: a new high frequency electrostimulation device to treat chronic prostatitis.
The Journal of urology 2004;171(6 Pt 1):2389; author reply 2389.
2004: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.
The New England journal of medicine 2004;350(22):2239-46.
2004: Javier Hernandez; Joseph W Basler; Ian M Thompson
The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.
The Urologic clinics of North America 2004;31(2):213-8.
2004: Eric A Klein; Ian M Thompson
Update on chemoprevention of prostate cancer.
Current opinion in urology 2004;14(3):143-9.
2004: Kanwaljit Mahal; Javier Hernandez; Joseph W Basler; Ian M Thompson
What's new in the field of prostate cancer chemoprevention?
Current oncology reports 2004;6(3):237-42.
2004: Bob Djavan; Ian M Thompson; M S Michel; Matthias Waldert; Christian Seitz
[Chemoprevention of prostate cancer].
Der Urologe. Ausg. A 2004;43(5):557-61.
2004: Phyllis J Goodman; Catherine M Tangen; John J Crowley; Susan M Carlin; Anne Ryan; Charles A Coltman; Leslie G Ford; Ian M Thompson
Implementation of the Prostate Cancer Prevention Trial (PCPT).
Controlled clinical trials 2004;25(2):203-22.
2004: Ian M Thompson; Robin J Leach; Dean A Troyer; Bradley Pollock; Susan Naylor; Betsy Higgins
Relationship of body mass index and prostate specific antigen in a population-based study.
Urologic oncology 2004;22(2):127-31.
2004: Javier Hernandez; Ian M Thompson
Diagnosis and treatment of prostate cancer.
The Medical clinics of North America 2004;88(2):267-79, ix.
2004: Ian M Thompson
Balancing cure and quality of life after radical prostatectomy.
The Journal of urology 2004;171(2 Pt 1):717-8.
2004: Catherine M Tangen; Phyllis J Goodman; John J Crowley; Ian M Thompson
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials.
The Journal of urology 2004;171(2 Pt 2):S64-7.
2004: Betsy Higgins; Ian M Thompson
The Prostate Cancer Prevention Trial: current status.
The Journal of urology 2004;171(2 Pt 2):S15-7; discussion S8.
2004: Albaha Barqawi; Ian M Thompson; E David Crawford
Prostate cancer chemoprevention: an overview of United States trials.
The Journal of urology 2004;171(2 Pt 2):S5-8; discussion S9.
2004: Ian M Thompson; Demetrius Albanes; Joseph W Basler; E David Crawford; Louis Denis; Bob Djavan; Neil Fleshner; Teresa Johnson-Pais; Eric A Klein; Alan R Kristal; M Scott Lucia; Howard L Parnes; Gary Piazza; Elizabeth A Platz; Bradley Pollock; Douglas K Price; Juergen K Reichardt; Catherine M Tangen; Anthony W Tolcher; Mary Carole McMann
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement.
The Journal of urology 2004;171(2 Pt 2):S3-4.
2003: Joseph M Unger; Michael LeBlanc; John J Crowley; H Barton Grossman; Ronald B Natale; Antoinette J Wozniak; James R Berenson; Alan F List; William A Peters; Robert C Flanigan; John S Macdonald; Muhyi Al-Sarraf; Ian M Thompson; Charles A Coltman
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23 Suppl):246s-252s.
2003: Ian M Thompson; Eric A Klein; Scott M Lippman; Charles A Coltman; Bob Djavan
Prevention of prostate cancer with finasteride: US/European perspective.
European urology 2003;44(6):650-5.
2003: Samira Syed; Tony Y Eng; Charles Thomas; Ian M Thompson; Geoffrey R Weiss
Current issues in the management of advanced squamous cell carcinoma of the penis.
Urologic oncology 2003;21(6):431-8.
2003: Edward M Messing; Ian M Thompson
Follow-up of conservatively managed prostate cancer: watchful waiting and primary hormonal therapy.
The Urologic clinics of North America 2003;30(4):687-702, viii.
2003: Lynn N Thomas; Robert C Douglas; J P Vessey; Rekha Gupta; D Fontaine; Richard W Norman; Ian M Thompson; Dean A Troyer; Roger S Rittmaster; Catherine B Lazier
5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
The Journal of urology 2003;170(5):2019-25.
2003: Carlos Bermejo; John Coursey; Joseph W Basler; Mark Austenfeld; Ian M Thompson
Histologic confirmation of lesions identified by Prostascint scan following definitive treatment.
Urologic oncology 2003;21(5):349-52; discussion 353.
2003: Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R. Duane Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
The influence of finasteride on the development of prostate cancer.
The New England journal of medicine 2003;349(3):215-24.
2003: Ian M Thompson; Robin J Leach; Bradley Pollock; Susan Naylor
Prostate cancer and prostate-specific antigen: the more we know, the less we understand.
Journal of the National Cancer Institute 2003;95(14):1027-8.
2003: Jeffrey A Leslie; Lloyd Stegemann; Alexander R Miller; Ian M Thompson
Metastatic seminoma presenting with pulmonary embolus, inferior vena caval thrombosis, and gastrointestinal bleeding.
Urology 2003;62(1):144.
2003: Angela Kamerer; Joseph W Basler; Ian M Thompson
Novel technique of Vest suture vesicourethral anastomosis in morbidly obese patient undergoing radical retropubic prostatectomy.
The Journal of urology 2003;170(1):174.
2003: Catherine M Tangen; James R Faulkner; E David Crawford; Ian M Thompson; Daisaku Hirano; Mario A Eisenberger; Maha Hussain
Ten-year survival in patients with metastatic prostate cancer.
Clinical prostate cancer 2003;2(1):41-5.
2003: Amjad Hammad; Gianmarco Paris; Wichard A J van Heuven; Ian M Thompson; Thomas D Fitzsimmons
Spontaneous regression of choroidal metastasis from renal cell carcinoma.
American journal of ophthalmology 2003;135(6):911-3.
2003: Samira Syed; Daniel P Petrylak; Ian M Thompson
Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches.
Urologic oncology 2003;21(3):235-43.
2003: Ian M Thompson; Catherine M Tangen; Phyllis Goodman
The Prostate Cancer Prevention Trial: design, status, and promise.
World journal of urology 2003;21(1):28-30.
2003: Eric A Klein; Scott M Lippman; Ian M Thompson; Phyllis J Goodman; Demetrius Albanes; Philip R Taylor; Charles A Coltman
The selenium and vitamin E cancer prevention trial.
World journal of urology 2003;21(1):21-7.
2003: Robin J Leach; Bradley Pollock; Joseph W Basler; Dean A Troyer; Susan Naylor; Ian M Thompson
Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials.
The Urologic clinics of North America 2003;30(2):227-37.
2003: Ian M Thompson; Joseph W Basler; Deborah Hensley; Dendra von Merveldt; Carol A Jenkins; Betsy Higgins; Robin J Leach; Dean A Troyer; Bradley Pollock
Prostate cancer prevention: what do we know now and when will we know more?
Clinical prostate cancer 2003;1(4):215-20.
2003: William E Grizzle; Bao-Ling Adam; William L Bigbee; Thomas P Conrads; Christopher Carroll; Ziding Feng; Elzbieta Izbicka; Moncef Jendoubi; Donald Johnsey; Jacob Kagan; Robin J Leach; Diane B McCarthy; O John Semmes; sudhir srivastava; Sudhir Srivastava; Ian M Thompson; Mark D Thornquist; Mukesh Verma; Zhen Zhang; Zhiqiang Zou
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer.
Disease markers 2003;19(4-5):185-95.
2003: Nicol S Corbin; Ian M Thompson
Urology and the Nobel Prize.
Urologic oncology 2003;21(1):83-5.
2003: Ian M Thompson; Joseph W Basler; Robin J Leach; Dean A Troyer; Eric Klein; Otis W Brawley
Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.
Urologic oncology 2003;21(1):73-8.
2003: Eric A Klein; Ian M Thompson; Scott M Lippman; Phyllis J Goodman; Demetrius Albanes; Philip R Taylor; Charles A Coltman
SELECT: the selenium and vitamin E cancer prevention trial.
Urologic oncology 2003;21(1):59-65.
2003: Jeffrey A Leslie; Tom Prihoda; Ian M Thompson
Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomes.
Urologic oncology 2003;21(1):39-44.
2003: Ian M Thompson
Informed consent for prostate cancer screening--a call for equity in medical interventions.
Urology 2003;61(1):15-6.
2003: Rodolfo Ibarra; Chris Magee; Hector Ferral; Ian M Thompson
Post-prostatectomy bleeding managed by endovascular embolization.
The Journal of urology 2003;169(1):276-7.
2003: Tracy R Glass; Catherine M Tangen; E David Crawford; Ian M Thompson
Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning.
The Journal of urology 2003;169(1):164-9.
2002: Donna K Pauler; Kathryn B Gower; Phyllis J Goodman; John J Crowley; Ian M Thompson
Biomarker-based methods for determining noncompliance in a prevention trial.
Controlled clinical trials 2002;23(6):675-85.
2002: Michael Sebesta; R. Duane Duane Cespedes; Eva Luhman; Scott Optenberg; Ian M Thompson
Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study population.
Urology 2002;60(6):1055-8.
2002: Ian M Thompson
Prostate cancer: wait or treat? How to apply new findings to your individual situation.
Health news (Waltham, Mass.) 2002;8(11):5.
2002: Alan A Nisbet; Ian M Thompson
Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangrene.
Urology 2002;60(5):775-9.
2002: Ivana Balic; Stanley T Graham; Dean A Troyer; Betsy A Higgins; Bradley Pollock; Teresa Johnson-Pais; Ian M Thompson; Robin J Leach
Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.
The Journal of urology 2002;168(5):2245-8.
2002: Isaac J Powell; Catherine M Tangen; Gary J Miller; Bruce A Lowe; Gabriel P Haas; Peter R Carroll; Michael B Osswald; Ralph W deVere White; Ian M Thompson; E David Crawford
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.
The Journal of urology 2002;168(5):2016-9.
2002: Alberto A Peña; Carlos Bermejo; Ian M Thompson
Ventral bladder hernia following tubal ligation.
The Journal of urology 2002;168(4 Pt 1):1502.
2002: Michael N Nitabach; D Alberto Llamas; Ian M Thompson; Kerry A Collins; Todd C Holmes
Phosphorylation-dependent and phosphorylation-independent modes of modulation of shaker family voltage-gated potassium channels by SRC family protein tyrosine kinases.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(18):7913-22.
2002: Ian M Thompson; Catherine M Tangen; Joseph W Basler; E David Crawford
Impact of previous local treatment for prostate cancer on subsequent metastatic disease.
The Journal of urology 2002;168(3):1008-12.
2002: Cristina Pelaez; Jeffrey A Leslie; Ian M Thompson
Adenocarcinoma in a colon conduit.
The Journal of urology 2002;167(4):1780.
2002: Robert A Zimmerman; Ian M Thompson
Prevalence of complementary medicine in urologic practice. A review of recent studies with emphasis on use among prostate cancer patients.
The Urologic clinics of North America 2002;29(1):1-9, vii.
2002: Rosemarie Plaetke; Ian M Thompson; Michael F Sarosdy; J M Harris; Dean A Troyer; Nedal Arar
Genetic fieldwork for hereditary prostate cancer studies.
Urologic oncology 2002;7(1):19-27.
2001: Boulos Toursarkissian; Alejandro Mejia; Michael H Wholey; M A Lawler; Ian M Thompson; Mellick T Sykes
Endovascular AAA repair in a patient with a horseshoe kidney and an isthmus mass.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2001;8(6):604-8.
2001: N Y Piper; JT Bishoff; C Magee; J M Haffron; R C Flanigan; A Mintiens; H P Van Poppel; Ian M Thompson; W J Harmon
Is a 1-CM margin necessary during nephron-sparing surgery for renal cell carcinoma?
Urology 2001;58(6):849-52.
2001: Ronald Lieberman; Carlos Bermejo; H Akaza; Peter Greenwald; W Fair; Ian M Thompson
Progress in prostate cancer chemoprevention: modulators of promotion and progression.
Urology 2001;58(6):835-42.
2001: Eric A Klein; Ian M Thompson; Scott M Lippman; Phyllis J Goodman; Demetrius Albanes; Philip R Taylor; Charles A Coltman
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.
The Journal of urology 2001;166(4):1311-5.
2001: Ashraful Hoque; Demetrius Albanes; Scott M Lippman; Margaret R Spitz; Philip R Taylor; Eric A Klein; Ian M Thompson; Phyllis Goodman; J L Stanford; John J Crowley; Charles A Coltman; Regina M Santella
Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Cancer causes & control : CCC 2001;12(7):627-33.
2001: Ian M Thompson
Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
The Journal of urology 2001;166(2):630.
2001: T Campbell; John C Blasko; E D Crawford; Jeffrey D Forman; Gerald Hanks; D Kuban; James E Montie; J Moul; Alan Pollack; D Raghavan; P Ray; M Roach; G Steinberg; N Stone; Ian M Thompson; N Vogelzang; Srinivasan Vijayakumar
Clinical staging of prostate cancer: reproducibility and clarification of issues.
International journal of cancer. Journal international du cancer 2001;96(3):198-209.
2001: Michelle L Hamilton; Z Guo; Clifton David Fuller; Holly Van Remmen; Walter F Ward; Steven Austad; Dean A Troyer; Ian M Thompson; Arlan G Richardson
A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA.
Nucleic acids research 2001;29(10):2117-26.
2001: Ian M Thompson
Latent carcinoma of the prostate.
European urology 2001;39 Suppl 4():41-2.
2001: Michael L Gallentine; Allen F Morey; Ian M Thompson
Hypospadias: a contemporary epidemiologic assessment.
Urology 2001;57(4):788-90.
2001: J Endrizzi; S Optenberg; R Byers; Ian M Thompson
Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy.
Urology 2001;57(4):733-6.
2001: Ian M Thompson
Making sense of PSA.
Health news (Waltham, Mass.) 2001;7(4):3.
2001: Ian M Thompson; M Kouril; Eric A Klein; Charles A Coltman; A Ryan; Phyllis Goodman
The Prostate Cancer Prevention Trial: Current status and lessons learned.
Urology 2001;57(4 Suppl 1):230-4.
2001: Ian M Thompson; Catherine M Tangen; A Tolcher; E Crawford; Mario A Eisenberger; Carol M Moinpour
Association of African-American ethnic background with survival in men with metastatic prostate cancer.
Journal of the National Cancer Institute 2001;93(3):219-25.
2001: P Carroll; C Coley; D McLeod; Paul F Schellhammer; G Sweat; J Wasson; A Zietman; Ian M Thompson
Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.
Urology 2001;57(2):225-9.
2001: P Carroll; C Coley; D McLeod; Paul F Schellhammer; G Sweat; J Wasson; A Zietman; Ian M Thompson
Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.
Urology 2001;57(2):217-24.
2001: Ian M Thompson
Flare Associated with LHRH-Agonist Therapy.
Reviews in urology 2001;3 Suppl 3():S10-4.
2001: Marian L Neuhouser; Alan R Kristal; Ruth E Patterson; Phyllis J Goodman; Ian M Thompson
Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials.
Nutrition and cancer 2001;39(1):12-8.
2000: Carol M Moinpour; J O Atkinson; S M Thomas; S M Underwood; C Harvey; J Parzuchowski; Laura C Lovato; A M Ryan; M S Hill; Edward P DeAntoni; Ellen R Gritz; Ian M Thompson; Charles A Coltman
Minority recruitment in the prostate cancer prevention trial.
Annals of epidemiology 2000;10(8 Suppl):S85-91.
2000: Joel M H Teichman; Ian M Thompson; N S Taichman
Joseph Parrish, tic doloureux of the bladder and interstitial cystitis.
The Journal of urology 2000;164(5):1473-5.
2000: Ian M Thompson; C A Coltman
Re: re: chemoprevention of urological cancer.
The Journal of urology 2000;164(4):1321-2.
2000: Ian M Thompson
Prostate cancer conundrum.
Health news (Waltham, Mass.) 2000;6(8):1-2.
2000: Joel M H Teichman; K D Anderson; M M Dorough; CR Stein; SA Optenberg; Ian M Thompson
The urology residency matching program in practice.
The Journal of urology 2000;163(6):1878-87.
2000: G S Matsunaga; D L Shepherd; Dean A Troyer; Ian M Thompson
Epididymal rhabdomyoma.
The Journal of urology 2000;163(6):1876.
2000: Carol M Moinpour; Laura C Lovato; Ian M Thompson; John Ware; Patricia Anne Ganz; D L Patrick; Sally A Shumaker; Gary W Donaldson; A Ryan; Charles A Coltman
Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1942-53.
2000: D M Selby; C Simon; J P Foley; Ian M Thompson; R T Baddour
Renal medullary carcinoma: can early diagnosis lead to long-term survival?
The Journal of urology 2000;163(4):1238.
2000: Ian M Thompson
Counseling patients with newly diagnosed prostate cancer.
Oncology (Williston Park, N.Y.) 2000;14(1):119-26, 131; discussion 135-6.
1999: Ian M Thompson; R G Middleton; SA Optenberg; M S Austenfeld; S R Smalley; W H Cooner; R J Correa; H C Miller; JE Oesterling; M I Resnick; John H Wasson; C G Roehrborn
Have complication rates decreased after treatment for localized prostate cancer?
The Journal of urology 1999;162(1):107-12.
1999: Ian M Thompson; S Optenberg; R Byers; M Dove
Increased incidence of testicular cancer in active duty members of the Department of Defense.
Urology 1999;53(4):806-7.
1999: Allen F Morey; M F MacDonald; Thomas Rozanski; S Natarajan; Ian M Thompson
Yield and efficacy of biopty gun testis needle biopsy.
Urology 1999;53(3):604-7.
1999: Joel M H Teichman; GJ Vassar; J T Yates; B N Angle; A J Johnson; M S Dirks; Ian M Thompson
Color vision deficits and laser eyewear protection for soft tissue laser applications.
The Journal of urology 1999;161(3):874-80.
1999: N Y Piper; Ian M Thompson
Large nephrogenic adenoma following transurethral resection of the prostate.
The Journal of urology 1999;161(2):605.
1999: C A Coltman; Ian M Thompson; P Feigl
Prostate Cancer Prevention Trial (PCPT) update.
European urology 1999;35(5-6):544-7.
1998: Joseph W Basler; Ian M Thompson
Lest we abandon digital rectal examination as a screening test for prostate cancer.
Journal of the National Cancer Institute 1998;90(23):1761-3.
1998: D Svetec; Ian M Thompson
PSA screening--current controversy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(12):1283-8.
1998: Otis W Brawley; Kevin B Knopf; Ian M Thompson
The epidemiology of prostate cancer part II: the risk factors.
Seminars in urologic oncology 1998;16(4):193-201.
1998: Mario A Eisenberger; Brent Blumenstein; E David Crawford; G Miller; D G McLeod; P J Loehrer; G Wilding; K Sears; D J Culkin; Ian M Thompson; A J Bueschen; Bruce A Lowe
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
The New England journal of medicine 1998;339(15):1036-42.
1998: D A Schow; L G Renfer; Thomas Rozanski; Ian M Thompson
Prevalence of hot flushes during and after neoadjuvant hormonal therapy for localized prostate cancer.
Southern medical journal 1998;91(9):855-7.
1998: Ian M Thompson; S F Flaherty; Allen F Morey
Battlefield urologic injuries: the Gulf War experience.
Journal of the American College of Surgeons 1998;187(2):139-41.
1998: J W Aquilina; L McKinney; A Pacelli; Laura K Richman; David J Waters; Ian M Thompson; W F Burghardt; D G Bostwick
High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer.
The Prostate 1998;36(3):189-93.
1998: JT Bishoff; G Motley; SA Optenberg; CR Stein; K A Moon; S M Browning; E Sabanegh; J P Foley; Ian M Thompson
Incidence of fecal and urinary incontinence following radical perineal and retropubic prostatectomy in a national population.
The Journal of urology 1998;160(2):454-8.
1998: Joel M H Teichman; GJ Vassar; Randolph Glickman; C M Beserra; S J Cina; Ian M Thompson
Holmium:YAG lithotripsy: photothermal mechanism converts uric acid calculi to cyanide.
The Journal of urology 1998;160(2):320-4.
1998: L Longmore; John P Foley; Thomas Rozanski; B Higgins; Ian M Thompson
Prolonged prostate-specific antigen response in flutamide withdrawal syndrome despite disease progression.
Southern medical journal 1998;91(6):573-5.
1998: Thomas Rozanski; F Salazar; Ian M Thompson
Direct vision bladder catheterization using a short rigid ureteroscope.
Urology 1998;51(5):827-8.
1998: D Svetec; K McCabe; S Peretsman; E Klein; H Levin; S Optenberg; Ian M Thompson
Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer.
The Journal of urology 1998;159(5):1606-8.
1998: E D Crawford; B Blumenstein; Ian M Thompson
Type III statistical error.
Urology 1998;51(4):675.
1998: J Allerton; T Seay; S Optenberg; C A Coltman; B Higgins; Ian M Thompson; Laura C Lovato
Army and Air Force leadership in the Prostate Cancer Prevention Trial.
Urology 1998;51(4A Suppl):64-6.
1998: J Stracener; D A Schow; L Renfer; Thomas Rozanski; Ian M Thompson
Radiographic characteristics of the vesicourethral anastomosis after radical retropubic and perineal prostatectomy.
Military medicine 1998;163(3):174-6.
1998: Joel M H Teichman; A J Johnson; J T Yates; B N Angle; M S Dirks; J T Muirhead; Ian M Thompson; Margaret S Pearle
Color vision deficits during laser lithotripsy using safety goggles for coumarin green or alexandrite but not with holmium:YAG laser safety goggles.
The Journal of urology 1998;159(3):683-9.
1998: J Y Clark; P K Lillis; T J O'Rourke; C Jones; B A Higgins; Ian M Thompson
Interobserver variability in prostate cancer specific survival.
Urologic oncology 1998;4(1):13-6.
1997: SA Optenberg; J Y Clark; M K Brawer; Ian M Thompson; CR Stein; P Friedrichs
Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test.
Urology 1997;50(5):665-72.
1997: Ian M Thompson; C A Coltman; J Crowley
Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.
The Prostate 1997;33(3):217-21.
1997: D A Svetec; E D Canby; Ian M Thompson; E S Sabanegh
The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction.
The Journal of urology 1997;158(5):1775-7.
1997: P A Friedrichs; J W Moul; B Wojcik; C Donatucci; S Optenberg; K Kreder; Ian M Thompson
A long-term study of the efficacy of treatment of localized prostate cancer.
Urologic oncology 1997;3(5-6):171-6.
1997: E David Crawford; Edward P DeAntoni; Maha Hussain; Ian M Thompson; Charles A Coltman
Prostate cancer clinical trials of the Southwest Oncology Group.
Oncology (Williston Park, N.Y.) 1997;11(8):1154-63; discussion 1163-70.
1997: Ian M Thompson; T M Seay
Will current clinical trials answer the most important questions about prostate adenocarcinoma?
Oncology (Williston Park, N.Y.) 1997;11(8):1109-17; discussion 1117-8, 1121.
1997: Ian M Thompson; Thomas Rozanski; John P Foley; M Harris
Facilitated radical perineal prostatectomy with the Brooke Bookwalter retractor blade.
Urology 1997;49(5):766-7.
1997: H B Grossman; Ian M Thompson
Summary of 125I implantation for carcinoma of prostate: further follow-up of first 100 cases (by H.B. Grossman, MD, M. Batata, MD, B. Hilaris, MD, and W.F. Whitmore, Jr, MD). 1982.
Seminars in urologic oncology 1997;15(2):111-4.
1997: Paul F Schellhammer; A Cockett; L Boccon-Gibod; M Gospodarowicz; A Krongrad; Ian M Thompson; Peter T Scardino; Mark S Soloway; J Adolfsson
Assessment of endpoints for clinical trials for localized prostate cancer.
Urology 1997;49(4A Suppl):27-38.
1997: Ian M Thompson
Prostate cancer.
The Journal of urology 1997;157(3):919-20.
1997: Ian M Thompson
What's new in urology.
Journal of the American College of Surgeons 1997;184(2):217-22.
1997: JA Mokulis; Ian M Thompson
Radical prostatectomy: is the perineal approach more difficult to learn?
The Journal of urology 1997;157(1):230-2.
1996: E J Mueller; E J Zeidman; P M Desmond; Ian M Thompson; SA Optenberg; J Wasson
Reduction of length of stay and cost of transurethral resection of the prostate by early catheter removal.
British journal of urology 1996;78(6):893-6.
1996: Rhonda L Cornum; S J Peretsman; Ian M Thompson
Influence of surgical approach on cancer control following radical prostatectomy.
Urologic oncology 1996;2(6):198-201.
1996: M J Harris; Ian M Thompson
The anatomic radical perineal prostatectomy: a contemporary and anatomic approach.
Urology 1996;48(5):762-8.
1996: Ian M Thompson
Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate.
Cancer 1996;78(1):181-2.
1996: P Lillis; Ian M Thompson
Should asymptomatic progression following definitive local treatment for prostate cancer be treated?
Hematology/oncology clinics of North America 1996;10(3):703-12.
1996: P M Lassen; Ian M Thompson; B Helfrick
Serum prostate-specific antigen concentration before and after vasectomy.
Military medicine 1996;161(6):356-7.
1996: Ian M Thompson; C A Coltman
Screening for prostate cancer: opportunities for prevention.
Seminars in urologic oncology 1996;14(2 Suppl 2):4-10; discussion 10-1.
1996: SA Optenberg; P Jacobs; Ian M Thompson; C R Stein
Use of New York Medicaid PASs (Products of Ambulatory Surgery) with emergency surgical episodes.
The Journal of ambulatory care management 1996;19(2):31-43.
1996: R Etzioni; Ian M Thompson
Prostate cancer and computer models: Background, limitations, and potential.
Urologic oncology 1996;2(2):57-64.
1996: O W Brawley; Ian M Thompson
The chemoprevention of prostate cancer and the Prostate Cancer Prevention Trial.
Cancer treatment and research 1996;88():189-200.
1995: R G Middleton; Ian M Thompson; M S Austenfeld; W H Cooner; R J Correa; Robert P Gibbons; H C Miller; J E Oesterling; M I Resnick; S R Smalley
Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association.
The Journal of urology 1995;154(6):2144-8.
1995: J Y Clark; Ian M Thompson; SA Optenberg
Economic impact of urolithiasis in the United States.
The Journal of urology 1995;154(6):2020-4.
1995: SA Optenberg; Ian M Thompson; P Friedrichs; B Wojcik; C R Stein; B Kramer
Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
JAMA : the journal of the American Medical Association 1995;274(20):1599-605.
1995: Ian M Thompson; S A Optenberg
An overview cost-utility analysis of prostate cancer screening.
Oncology (Williston Park, N.Y.) 1995;9(11 Suppl):141-5.
1995: J T Bishoff; Ian M Thompson
Commissary tobacco sales: the elimination of a historic artifact.
Military medicine 1995;160(11):543-4.
1995: R. Duane Duane Cespedes; S J Peretsman; Ian M Thompson; C Jackson
Protection of the germinal epithelium in the rat from the cytotoxic effects of chemotherapy by a luteinizing hormone-releasing hormone agonist and antiandrogen therapy.
Urology 1995;46(5):688-91.
1995: K C Shandera; Ian M Thompson; R W Wong; A F Cossi
Delayed development of mid-ileal conduit stenosis: the importance of life-long urologic follow-up.
Southern medical journal 1995;88(11):1118-20.
1995: L G Renfer; D Schow; Ian M Thompson; S Optenberg
Is ultrasound guidance necessary for transrectal prostate biopsy?
The Journal of urology 1995;154(4):1390-1.
1995: J A Mokulis; W F Arndt; J R Downey; R L Caballero; Ian M Thompson
Should renal ultrasound be performed in the patient with microscopic hematuria and a normal excretory urogram?
The Journal of urology 1995;154(4):1300-1.
1995: Gleen J Gormley; Otis W Brawley; Ian M Thompson
The potential application of finasteride for chemoprevention of prostate cancer.
Annals of the New York Academy of Sciences 1995;768():163-9.
1995: K C Shandera; Ian M Thompson
Intraperitoneal urinary extravasation associated with infected urachal cyst.
The Journal of urology 1995;154(3):1130-1.
1995: SA Optenberg; B E Wojcik; Ian M Thompson
Morbidity and mortality following radical prostatectomy: a national analysis of Civilian Health and Medical Program of the Uniformed Services beneficiaries.
The Journal of urology 1995;153(6):1870-2.
1995: L Renfer; Ian M Thompson; P M Desmond; E J Zeidman; E J Mueller
Balloon dilation of the prostate: correlation with magnetic resonance imaging and transrectal ultrasound findings.
Journal of endourology / Endourological Society 1995;9(3):283-6.
1995: P Feigl; B Blumenstein; Ian M Thompson; J Crowley; M Wolf; B S Kramer; C A Coltman; Otis W Brawley; Leslie G Ford
Design of the Prostate Cancer Prevention Trial (PCPT).
Controlled clinical trials 1995;16(3):150-63.
1995: Ian M Thompson; C A Coltman; O W Brawley; A Ryan
Chemoprevention of prostate cancer.
Seminars in urology 1995;13(2):122-9.
1995: Ian M Thompson
Prostate cancer screening.
Archives of family medicine 1995;4(4):307-8.
1995: E J Mueller; J Coventry; P M Desmond; E J Zeidman; Ian M Thompson
Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate.
Urologic oncology 1995;1(2):84-7.
1995: J T Bishoff; A Reyes; Ian M Thompson; M J Harris; S R St Clair; L Gomella; C A Butzin
Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection.
Urology 1995;45(2):270-4.
1995: E David Crawford; Maha Hussain; Edward P DeAntoni; Ian M Thompson; Mario A Eisenberger; B Blumenstein; C A Coltman
Southwest Oncology Group strategies in prostatic carcinoma.
Seminars in surgical oncology 1995;11(1):60-4.
1995: Ian M Thompson; P Feigl; C Coltman
Chemoprevention of prostate cancer with finasteride.
Important advances in oncology 1995;():57-76.
1994: W L Lubke; S A Optenberg; Ian M Thompson
Analysis of the first-year cost of a prostate cancer screening and treatment program in the United States.
Journal of the National Cancer Institute 1994;86(23):1790-2.
1994: Ian M Thompson; J C Paradelo; E D Crawford; C A Coltman; B Blumenstein
An opportunity to determine optimal treatment of pT3 prostate cancer: the window may be closing.
Urology 1994;44(6):804-11.
1994: M E Marshall; B Blumenstein; E D Crawford; Ian M Thompson; J B Craig; Mario A Eisenberger; F Ahmann
Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
American journal of clinical oncology 1994;17(6):514-5.
1994: J Y Clark; Ian M Thompson
Military rank as a measure of socioeconomic status and survival from prostate cancer.
Southern medical journal 1994;87(11):1141-4.
1994: M S Austenfeld; Ian M Thompson; R G Middleton
Meta-analysis of the literature: guideline development for prostate cancer treatment. American Urological Association Prostate Cancer Guideline Panel.
The Journal of urology 1994;152(5 Pt 2):1866-9.
1994: Ian M Thompson
Prostate cancer and quality of life.
The Journal of urology 1994;152(4):1180.
1994: K C Shandera; Ian M Thompson
Urologic prostheses.
Emergency medicine clinics of North America 1994;12(3):729-48.
1994: O W Brawley; Ian M Thompson
Chemoprevention of prostate cancer.
Urology 1994;43(5):594-9.
1994: P Narayan; B A Lowe; Peter R Carroll; Ian M Thompson
Neoadjuvant hormonal therapy and radical prostatectomy for clinical stage C carcinoma of the prostate.
British journal of urology 1994;73(5):544-8.
1994: P M Lassen; Ian M Thompson
Treatment options for prostate cancer.
Urologic nursing 1994;14(1):12-5.
1994: R. Duane Duane Cespedes; R L Caballero; S J Peretsman; Ian M Thompson
Cryptic presentations of germ cell tumors.
Journal of the American College of Surgeons 1994;178(3):261-5.
1994: Otis W Brawley; Leslie G Ford; Ian M Thompson; J A Perlman; B S Kramer
5-Alpha-reductase inhibition and prostate cancer prevention.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(2):177-82.
1994: Ian M Thompson
Observation alone in the management of localized prostate cancer: the natural history of untreated disease.
Urology 1994;43(2 Suppl):41-6.
1994: Judd W Moul; F J Schanne; Ian M Thompson; H A Frazier; S A Peretsman; J N Wettlaufer; Thomas Rozanski; R S Stack; K J Kreder; K J Hoffman
Testicular cancer in blacks. A multicenter experience.
Cancer 1994;73(2):388-93.
1994: E J Zeidman; B Helfrick; C Pollard; Ian M Thompson
Bacillus Calmette-Guérin immunotherapy for refractory interstitial cystitis.
Urology 1994;43(1):121-4.
1994: J L Mohler; B T Williams; Ian M Thompson; M E Marshall
Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.
Journal of cancer research and clinical oncology 1994;120 Suppl():S35-8.
1993: Glenn S Gerber; Ronald A Thisted; G W Chodak; Ian M Thompson
Disease-specific survival following routine prostate cancer screening by digital rectal examination: corrected patient classification.
JAMA : the journal of the American Medical Association 1993;270(20):2437.
1993: P M Desmond; J Clark; Ian M Thompson; E J Zeidman; E J Mueller
Morbidity with contemporary prostate biopsy.
The Journal of urology 1993;150(5 Pt 1):1425-6.
1993: W S Kearse; T M Seay; Ian M Thompson
The long-term risk of development of prostate cancer in patients with benign prostatic hyperplasia: correlation with stage A1 disease.
The Journal of urology 1993;150(5 Pt 2):1746-8.
1993: Leopoldo Cancio; E S Sabanegh; Ian M Thompson
Managing the Foley catheter.
American family physician 1993;48(5):829-36.
1993: J P Spirnak; W L Lubke; Ian M Thompson; M Lopez
Dystrophic bladder wall calcifications following intravesical BCG treatment for superficial transitional cell carcinoma of bladder.
Urology 1993;42(1):89-92.
1993: W L Lubke; Ian M Thompson
The case for inguinal lymph node dissection in the treatment of T2-T4, N0 penile cancer.
Seminars in urology 1993;11(2):80-4.
1993: T K Dixon; M L Ritchey; W Boykin; B Harper; E Zeidman; Ian M Thompson
Transparenchymal suture fixation and testicular histology in a prepubertal rat model.
The Journal of urology 1993;149(5):1116-8.
1993: Glenn S Gerber; Ian M Thompson; Ronald A Thisted; Gerald Chodak
Disease-specific survival following routine prostate cancer screening by digital rectal examination.
JAMA : the journal of the American Medical Association 1993;269(1):61-4.
1992: W H Boykin; K E Bright; E J Zeidman; Ian M Thompson
Renal tumors in young adults.
Urology 1992;40(6):503-5.
1992: T H Phillips; E J Zeidman; Ian M Thompson
The fate of buried vaginal epithelium.
The Journal of urology 1992;148(6):1941-3.
1992: Ian M Thompson; E J Zeidman
Current urological practice: routine urological examination and early detection of carcinoma of the prostate.
The Journal of urology 1992;148(2 Pt 1):326-9; discussion 329-30.
1992: E J Zeidman; P Desmond; Ian M Thompson
Surgical treatment of carcinoma of the male urethra.
The Urologic clinics of North America 1992;19(2):359-72.
1992: M E Hooten; K Finstuen; Ian M Thompson
Multivariate case-control study of survival following transurethral resection of prostate.
Urology 1992;39(2):111-6.
1992: Ian M Thompson; G W Chodak
The natural history of adenocarcinoma of the prostate.
Journal of cellular biochemistry. Supplement 1992;16H():20-5.
1992: R D Williams; D G Bostwick; C W Boone; W J Catalona; W McKeehan; Ian M Thompson
When is intervention warranted?
Journal of cellular biochemistry. Supplement 1992;16H():138-9.
1991: A W Mazur; Ian M Thompson
Efficacy and morbidity of "channel" TURP.
Urology 1991;38(6):526-8.
1991: D Corrie; E J Mueller; Ian M Thompson
Management of ultrasonically detected nonpalpable testis masses.
Urology 1991;38(5):429-31.
1991: T H Phillips; Ian M Thompson
Digital rectal examination and carcinoma of the prostate.
The Urologic clinics of North America 1991;18(3):459-65.
1991: K L Hansberry; Ian M Thompson; J Bauman; S Deppe; F R Rodriguez
A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium/dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery.
The Journal of urology 1991;145(6):1205-8.
1991: W F Whitmore; J A Warner; Ian M Thompson
Expectant management of localized prostatic cancer.
Cancer 1991;67(4):1091-6.
1991: E S Sabanegh; Ian M Thompson
Fulguration of urethral condylomata: modified technique using visual urethrotome.
Urology 1991;37(2):172.
1991: Ian M Thompson; E J Zeidman
Presentation and clinical course of patients ultimately succumbing to carcinoma of the prostate.
Scandinavian journal of urology and nephrology 1991;25(2):111-4.
1990: Ian M Thompson; F R Rodriguez; E J Zeidman
Experience with Duraphase penile prosthesis: its use as replacement device.
Urology 1990;36(6):505-7.
1990: Ian M Thompson; E J Zeidman; F R Rodriguez
Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate.
The Journal of urology 1990;144(6):1479-80.
1990: S A Optenberg; Ian M Thompson
Economics of screening for carcinoma of the prostate.
The Urologic clinics of North America 1990;17(4):719-37.
1990: Ian M Thompson; A C Marx
Conservative therapy of rectourethral fistula: five-year follow-up.
Urology 1990;35(6):533-6.
1990: Carol M Moinpour; K A Hayden; Ian M Thompson; P Feigl; B Metch
Quality of life assessment in Southwest Oncology Group trials.
Oncology (Williston Park, N.Y.) 1990;4(5):79-84, 89; discussion 104.
1989: D Corrie; F R Rodriguez; Ian M Thompson
Periurethral polytetrafluoroethylene injections for post-prostatectomy incontinence.
Military medicine 1989;154(9):442-4.
1989: Ian M Thompson; E J Zeidman
Extended follow-up of stage A1 carcinoma of prostate.
Urology 1989;33(6):455-8.
1989: W Boykin; F R Rodriguez; J P Brizzolara; Ian M Thompson; E J Zeidman
Complete urinary obstruction following periurethral polytetrafluoroethylene injection for urinary incontinence.
The Journal of urology 1989;141(5):1199-200.
1989: Ian M Thompson
Carcinoma of the prostate: changing incidence associated with annual urologic screening.
Southern medical journal 1989;82(3):335-7.
1989: C L Truwit; M Jackson; Ian M Thompson
Idiopathic macroorchidism.
Journal of clinical ultrasound : JCU 1989;17(3):200-5.
1989: Ian M Thompson; W R Fair
Screening for carcinoma of the prostate: efficacy of available screening tests.
World journal of surgery 1989;13(1):65-70.
1988: E J Mueller; Ian M Thompson
Bladder carcinoma presenting as exercise-induced hematuria.
Postgraduate medicine 1988;84(8):173-6.
1988: E J Mueller; T W Crain; Ian M Thompson; F R Rodriguez
An evaluation of serial digital rectal examinations in screening for prostate cancer.
The Journal of urology 1988;140(6):1445-7.
1988: Ian M Thompson; M Peek
Improvement in survival of patients with renal cell carcinoma--the role of the serendipitously detected tumor.
The Journal of urology 1988;140(3):487-90.
1988: D Corrie; J H Timmons; J M Bauman; Ian M Thompson
Efficacy of follow-up bone scans in carcinoma of the prostate.
Cancer 1988;61(12):2453-4.
1988: Ian M Thompson; J B Rounder; C R Spence; F R Rodriguez
Salvage radical prostatectomy for adenocarcinoma of the prostate.
Cancer 1988;61(7):1464-6.
1988: Ian M Thompson; M Baikadi; J Berchmans; M Berkland; R Ortiz
Perineal recurrence of adenocarcinoma of prostate following radiation therapy.
Urology 1988;31(3):198-201.
1987: C N Barrilleaux; R C Leib; Ian M Thompson
Mechanical gastric outlet obstruction after continent urinary diversion.
The Journal of urology 1987;138(6):1433-4.
1987: Ian M Thompson; F R Rodriguez; C R Spence
Medullary sponge kidney and congenital hemihypertrophy.
Southern medical journal 1987;80(11):1455-6.
1987: Ian M Thompson
The evaluation of microscopic hematuria: a population-based study.
The Journal of urology 1987;138(5):1189-90.
1987: Ian M Thompson; C R Spence; D L Lamm; N R DiLuzio
Immunochemotherapy of bladder carcinoma with glucan and cyclophosphamide.
The American journal of the medical sciences 1987;294(5):294-300.
1987: D Corrie; Ian M Thompson
The value of retrograde pyelography for fractionally visualized upper tracts on excretory urography in the evaluation of hematuria.
The Journal of urology 1987;138(3):554-6.
1987: D Corrie; J C Norbeck; Ian M Thompson; F Rodriguez; J L Teague; J B Rounder; C R Spence
Ultrasound detection of bilateral Leydig cell tumors in palpable normal testes.
The Journal of urology 1987;137(4):747-8.
1987: Ian M Thompson; J L Teague; E J Mueller; F R Rodriguez
Intravesical alum irrigation for intractable bleeding secondary to adenocarcinoma of the prostate.
The Journal of urology 1987;137(3):525-6.
1987: Ian M Thompson; J B Rounder; J L Teague; M Peek; C R Spence
Impact of routine screening for adenocarcinoma of the prostate on stage distribution.
The Journal of urology 1987;137(3):424-6.
1987: Ian M Thompson; M Peek; F R Rodriguez
The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder.
The Journal of urology 1987;137(3):401-3.
1987: Ian M Thompson; R A Watson; F R Rodriguez
TURP followed by intraoperative hemorrhage incontinence.
Military medicine 1987;152(1):50-1.
1986: Ian M Thompson; R A Watson; F R Rodriguez
Medicolegal ramifications of surgical practice.
Military medicine 1986;151(12):670-1.
1985: Ian M Thompson; R V Mora; M P Gangai; C R Spence
Treatment of childhood bilateral vas transection with cutaneous vasostomy.
Military medicine 1985;150(5):275-7.
1984: Ian M Thompson; R V Mora
Hypermagnesemia associated with hemiacidrin irrigation.
The Journal of urology 1984;132(4):741-2.
1984: Ian M Thompson; J J Ernst; M P Gangai; C R Spence
Adenocarcinoma of the prostate: results of routine urological screening.
The Journal of urology 1984;132(4):690-2.
1983: K R Bryant; Ian M Thompson; R Ortiz; C R Spence
Urethral paraganglioma presenting as a urethral polyp.
The Journal of urology 1983;130(3):571-2.
1983: Ian M Thompson; F G Boineau; B B Evans; J U Schlegel
The renal quantitative scintillation camera study for determination of renal function.
The Journal of urology 1983;129(3):461-5.
1981: Ian M Thompson; A Kovac; J Geshner
Coronal renal ultrasound: II.
Urology 1981;17(2):210-3.
1981: Ian M Thompson; A Kovac; J Geshner; D Serma
Coronal renal ultrasound: I.
Urology 1981;17(1):92-4.
1980: Ian M Thompson; A Kovac; J Geshner
Ultrasound followup of renal cyst puncture.
The Journal of urology 1980;124(2):175-8.